Hyperforin is a dual inhibitor of cyclooxygenase-1 and 5-lipoxygenase (Q28169147)

6

object named as

Oliver Werz

0 references

author name string

Dana Albert

1

0 references

Ilse Zündorf

2

0 references

Theo Dingermann

3

0 references

Walter E Müller

St John's wort for depression: a systematic review

4

0 references

language of work or name

English

0 references

publication date

15 December 2002

0 references

published in

Biochemical Pharmacology

0 references

volume

64

0 references

issue

12

0 references

page(s)

1767-75

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901387-4

St. John's wort (Hypericum perforatum): a review of the current pharmacological, toxicological, and clinical literature.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901387-4

St John's wort: Prozac from the plant kingdom.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901387-4

St John's wort for depression--an overview and meta-analysis of randomised clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901387-4

St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901387-4

Hyperforin as a possible antidepressant component of hypericum extracts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901387-4

Adhyperforin as a contributor to the effect of Hypericum perforatum L. in biochemical models of antidepressant activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901387-4

Antibacterial activity of hyperforin from St John's wort, against multiresistant Staphylococcus aureus and gram-positive bacteria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901387-4

Antibacterial activity of hyperforin from St John's wort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901387-4

Topical application of St John's wort (Hypericum perforatum L.) and of its metabolite hyperforin inhibits the allostimulatory capacity of epidermal cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901387-4

St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901387-4

Prostaglandin endoperoxide synthases-1 and -2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901387-4

Leukotrienes and lipoxins: structures, biosynthesis, and biological effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901387-4

Do cyclooxygenase-2 inhibitors provide benefits similar to those of traditional nonsteroidal anti-inflammatory drugs, with less gastrointestinal toxicity?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901387-4

Anti-inflammatory drugs: new multitarget compounds to face an old problem. The dual inhibition concept.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901387-4

Dual acting anti-inflammatory drugs: a reappraisal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901387-4

Sequential induction of 5-lipoxygenase gene expression and activity in Mono Mac 6 cells by transforming growth factor beta and 1,25-dihydroxyvitamin D3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901387-4

Selenium-dependent peroxidases suppress 5-lipoxygenase activity in B-lymphocytes and immature myeloid cells. The presence of peroxidase-insensitive 5-lipoxygenase activity in differentiated myeloid cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901387-4

Mutations at the C‐Terminal Isoleucine and Other Potential Iron Ligands of 5‐Lipoxygenase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901387-4

Nonredox 5-lipoxygenase inhibitors require glutathione peroxidase for efficient inhibition of 5-lipoxygenase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901387-4

Monoclonal antibodies against E- and F-type prostaglandins. High specificity and sensitivity in conventional radioimmunoassays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901387-4

Isoenzyme-specific cyclooxygenase inhibitors: a whole cell assay system using the human erythroleukemic cell line HEL and the human monocytic cell line Mono Mac 6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901387-4

Oral bioavailability of hyperforin from hypericum extracts in rats and human volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901387-4

Preclinical and clinical activity of zileuton and A-78773

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901387-4

Biologically active and other chemical constituents of the herb of Hypericum perforatum L.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901387-4

Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901387-4

Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901387-4

Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901387-4

Cyclooxygenase 1 contributes to inflammatory responses in rats and mice: implications for gastrointestinal toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901387-4

The effect of leukotriene synthesis inhibitors in models of acute and chronic inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901387-4

10.1016/S0006-2952(02)01387-4

7 January 2021

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

12445866

1 reference

Consolidated OpenCitations Corpus – April 2017